Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTT-621 in Moderately to Severely Active Ulcerative Colitis
NCT07747155Phase 2Not yet recruiting
- Sponsor
- Pyrotech Therapeutics
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of PTT-621 in ulcerative colitis (UC), sponsored by Pyrotech Therapeutics. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
PTT-621
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07747155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747155.